Summary Safety Review - Proton Pump Inhibitors (PPIs) - Assessing the risk of a type of skin reaction [Subacute Cutaneous Lupus Erythematosus (SCLE)]

Health Canada reviewed the potential risk of a type of skin reaction known as subacute cutaneous lupus erythematosus(SCLE) with the use of PPIs after a published article that found these drugs may contribute to the reaction.

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 17:34 (UTC)
Created April 17, 2026, 17:34 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2020-12-04 00:00:00
open_canada_keywords {"fr": ["Summary Safety Review", "Proton Pump Inhibitors", "PPIs", "assessing", "risk", "skin reaction", "Subacute Cutaneous Lupus Erythematosus"], "en": ["Summary Safety Review", "Proton Pump Inhibitors", "PPIs", "assessing", "risk", "skin reaction", "Subacute Cutaneous Lupus Erythematosus"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Summary Safety Review - Proton Pump Inhibitors (PPIs) - Assessing the risk of a type of skin reaction [Subacute Cutaneous Lupus Erythematosus (SCLE)]
update_frequency as_needed